Related Experiment Videos
Abnormal platelet aggregation measured by screen filtration pressure (sfp) in coronary heart disease: a new risk
Acta Cardiologica
|January 1, 1980
Insights
Coronary heart disease patients showed higher platelet aggregate filtration pressure (PAFP) than controls. This suggests platelet hyperaggregation may independently contribute to coronary heart disease development.
Area of Science:
- Cardiovascular Medicine
- Hematology
- Clinical Physiology
Background:
- Coronary heart disease (CHD) is a leading cause of mortality.
- Arteriosclerosis development is multifactorial, involving traditional risk factors.
- The role of platelet function in CHD pathogenesis requires further elucidation.
Purpose of the Study:
- To investigate platelet aggregate filtration pressure (PAFP) in male patients with coronary heart disease (CHD).
- To assess the potential independent role of platelet hyperaggregation in CHD development, excluding common risk factors.
Main Methods:
- Measurement of platelet aggregate filtration pressure (PAFP) in mmHg.
- Comparison of PAFP values between a group of 38 male CHD patients and a control group.
- Patients were selected to be free from known arteriosclerosis risk factors.
Main Results:
- Significantly higher mean PAFP values were observed in the CHD group compared to the control group (p < 0.05).
- This finding indicates increased platelet aggregation in CHD patients even in the absence of traditional risk factors.
Conclusions:
- Elevated PAFP suggests a potential independent role for platelet hyperaggregation in the development of coronary heart disease.
- Further research is warranted to confirm the direct causal link between platelet hyperaggregation and CHD pathogenesis.
Abstract:
Platelet aggregate filtration pressure PAFP) has been measured in 38 male coronary heart disease patients (CHD) free from "risk factors" for the development of arteriosclerosis. Significantly (p less than 0.05) higher mean PAFP values (mmHg) were found in the CHD group as compared to the "control" group. Such finding suggests, though does not demonstrate, the "independent" role of platelet hyperaggregation in the development of CHD.